Catalyst

Slingshot members are tracking this event:

ZIOPHARM (ZIOP) to launch Phase 1 study of a viral-based CAR T-cell therapy for myeloid malignancies in 2016

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
XON

100%
ZIOP

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 28, 2017
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 1 Study, Car-t, Myeloid Leukemia, Viral-based Car-t, Cd-33